<DOC>
	<DOCNO>NCT02004314</DOCNO>
	<brief_summary>This study evaluate effect chloroquine individual infect HIV . Researchers aim determine chloroquine treatment participant whose viral load suppress combination antiretroviral therapy ( ART ) , result improve immune activation CD4 cell recovery . The study recruit 20 individual last approximately 44 week . Eligible participant receive oral dose chloroquine ( 250 mg ) daily week 8 week 32 . All participant ask rectal biopsy sample ( week 0 week 32 ) study T cell immune activation mucosa rectal site .</brief_summary>
	<brief_title>Chloroquine Modulator T Cell Immune Activation</brief_title>
	<detailed_description>Clinical data identify chloroquine potential modulator immune activation . The study 's dose chloroquine dose recommend patient autoimmune disease . In autoimmune case , daily dose chloroquine 250 mg 12 week show improvement symptom decrease inflammatory cytokine synthesis reduction TLR -mediated immune activation . Study finding could help provide information circumstance chloroquine treatment may reduce T cell activation help restore circulate CD4 T cell .</detailed_description>
	<mesh_term>Chloroquine</mesh_term>
	<mesh_term>Chloroquine diphosphate</mesh_term>
	<criteria>Documented HIV infection Western Blot , EIA assay viral load assay . Aged 18 65 year . Viral load le 50 copy per ml least previous 36 week . CD4 cell count less equal 350 cell per litre . On stable ART Vital sign , physical examination laboratory result exhibit evidence disease advance cirrhosis advance liver Karnofsky performance status great equal 80 per cent . Participant require agrees take , duration study , medication contraindicate chloroquine . Able give inform consent . Active AIDS event last 3 month Coinfection active hepatitis B C virus . Current use use within four week prior baseline visit , cytotoxic agent , systemic corticosteroid immunomodulatory agent . Current use within four week prior chloroquine therapy follow medication : methadone , chlorpromazine , cimetidine , cyclosporin , methotrexate penicillanime . Psychiatric cognitive disturbance illness could preclude compliance study . Patient clinically significant hemophilia VonWillebrand disease severe bleed disorder . Experimental HIV immune base therapy within 6 month screen visit . Allergic reaction chloroquine . A history retinitis retinal problem . Subjects G6PD deficiency , porphyria , psoriasis , cirrhosis , hear deficiency ( include tinnitus ) , myopathy cardiomyopathy . Pregnant breastfeed woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Chloroquine</keyword>
	<keyword>T cell immune activation</keyword>
	<keyword>CD4 recovery</keyword>
	<keyword>HIV</keyword>
</DOC>